Health Topics

Does COVID-19 increase the risk of digestive diseases?

18Jan

By Dr. Antonia ThompsonNo Comments

News & Events, Health Topics

Does COVID-19 increase the risk of digestive diseases?

Does COVID-19 increase the risk of digestive diseases? The specter of COVID-19 continues to loom, its long-term effects a complex tapestry woven with unexpected threads. One alarming strand emerging from this tapestry is the potential link between COVID-19 and a rise in digestive diseases. While the full picture is still developing, recent research suggests a worrying trend, raising questions about the virus's lasting impact on our gut health. Digestive Distress in the Aftermath: While initial COVID-19 symptoms often focus on respiratory issues, studies reveal a significant number of patients experiencing digestive woes alongside fever and cough. Diarrhea, nausea, vomiting, and abdominal pain are not uncommon, with some reports suggesting up to one in five patients experiencing the...

Kidney Stones? Alkaline Water May Not Be Your Kidney Stone Savior

Kidney Stones? Alkaline Water May Not Be Your Kidney Stone Savior Kidney stones, those tiny, agonizing pebbles that wreak havoc on your urinary tract, are an unwelcome guest in anyone's life. Seeking relief and prevention is understandable, and the allure of alkaline water, marketed as a natural stone-dissolving elixir, is tempting. But before you guzzle gallons in hopes of a miracle, let's separate fact from fizz and explore the truth about alkaline water and its impact on kidney stones. Unveiling the Alkaline Allure: Alkaline water boasts a pH level higher than regular water, typically ranging from 8 to 9.5. Proponents claim this higher pH can neutralize acidic urine, the prime culprit behind certain types of kidney stones, particularly those composed of calcium oxalate, the most co...

New Alzheimer’s Treatment Enhances Drug Delivery to the Brain

A Beacon of Hope in the Battle Against Alzheimer's: New Treatment Enhances Drug Delivery to the Brain New Alzheimer's Treatment Enhances Drug Delivery to the Brain Alzheimer's disease, a neurodegenerative condition robbing millions of their memories and independence, has long been a formidable foe. But a recent breakthrough offers a glimmer of hope, highlighting a novel approach to delivering crucial drugs directly to the brain, the disease's epicenter. This game-changer, detailed in a study published in Nature Medicine, focuses on enhancing the effectiveness of an existing Alzheimer's medication called aducanumab. Though approved by the FDA in 2021, aducanumab's efficacy was initially dampened by its limited ability to penetrate the blood-brain barrier, the protective wall separati...